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os Angeles, California
therosclerotic plaques responsible for coronary heart dis-
ase are heterogeneous in their composition, containing a
ariable amount of lipid, scar tissue, calcium, neovessels,
nflammatory cells, and thrombotic material (1). In com-
arison with lesions found in stable coronary heart disease,
oronary lesions responsible for acute coronary syndromes
ACS) consist of disrupted plaques with superimposed
hrombus, and disrupted plaques in turn tend to have larger
ecrotic lipid cores and greater plaque inflammation (1).
See pages 1635 and 1641
pontaneous distal embolization of thrombus or atheroma-
ous gruel from the epicardial culprit lesion is common in
CS and might be further triggered by percutaneous
oronary interventions (PCIs) (2,3). Factors that increase
he risk of distal embolization include PCI of vein grafts
ontaining large amounts of friable atheroma, PCI on
ulprit lesions containing thrombus responsible for ACS,
nd the use of atherectomy. Distal embolization leads to
icrovascular obstruction, sluggish flow, or no-reflow and
as been postulated to result in myocardial necrosis; how-
ver, not all forms of sluggish or no-reflow are due to distal
mbolization. Slow flow or no-reflow in ACS might also be
he consequence of microvascular vasoconstriction and mi-
rovascular damage resulting from extensive myocardial
ecrosis, in which case it might be a marker rather than
irect contributor to myocardial damage (4–6). The clinical
nd prognostic impact of post-PCI distal embolization is
ot unambiguously established, although it is plausible that
istal embolization could obstruct nutritive flow to viable
Editorials published in the Journal of American College of Cardiology reflect the views
f the authors and do not necessarily represent the views of JACC or the American
ollege of Cardiology.
From the Division of Cardiology and the Atherosclerosis Research Center, the
urns and Allen Research Institute and the Department of Medicine, Cedars SinaiS
edical Center and David Geffen School of Medicine at UCLA, Los Angeles,
alifornia.yocardium, thereby inducing necrosis with an adverse
ffect on clinical outcome; however, no-reflow occurring as
consequence of necrosis would not have any direct effect
n outcome independent of the extent and severity of
nderlying necrosis (4–6). Regardless of the mechanism,
low flow or no-reflow after PCI is generally associated with
n adverse clinical outcome in ACS (7).
In this issue of the Journal, 2 papers report on the
elationship between measures of plaque composition and
he frequency of post-PCI distal embolization in patients
ith ST-segment elevation myocardial infarction (STEMI)
8) or angina (9). The plaque composition was assessed by
irtual Histology intravascular ultrasound (VH-IVUS)
Volcano Therapeutics, Inc., Rancho Cordova, California)
n which spectral analysis of radiofrequency ultrasound
ackscatter signals from the IVUS images are evaluated to
efine fibrous area, fibro-fatty area, dense calcific area, and
ecrotic core area within the plaque (10). In the first study,
1 patients with STEMI undergoing primary PCI were
valuated for evidence of distal embolization after stenting,
ith ST segment re-elevation (corroborated by increased
orrected Thrombolysis In Myocardial Infarction [TIMI]-
rame count) as a marker of distal embolization. Before
tenting, the culprit lesion was subjected to mechanical
hrombectomy followed by IVUS examination, and VH-
VUS was used to characterize plaque constituents. The
ecrotic core volume in the culprit lesion was the major
irect correlate of distal embolization, which occurred in
5.5% of patients: a necrotic core volume of 33.4 mm3
redicted distal embolization with 82% sensitivity and 64%
pecificity (8). Pre-stent thrombectomy alone also induced
istal embolization in 13 (18%) patients. In another study,
4 patients with angina undergoing PCI were evaluated for
igns of distal embolization (9). Distal embolization was
etected by the number of high-intensity transient signals
HITS) with a Doppler guidewire (11,12). Once again, the
ecrotic core size by VH-IVUS before PCI was an inde-
endent predictor of distal embolization, and patients in the
ighest tertile of HITS count had a significantly larger
ecrotic core area compared with patients in lower tertiles
9). Although both studies come to similar conclusions,
everal issues must be considered to place these interesting
bservations into perspective. First of all, both studies had a
mall sample size and the findings were not prospectively
alidated in an independent additional cohort of patients;
hus the observations must be considered preliminary. Sec-
nd, the patterns observed on VH-IVUS do not consis-
ently correlate with histology, raising concerns that infer-
nces from VH-IVUS as to identity of plaque components
ust be taken with a grain of salt (10,13,14). Third, even if
ne were to assume that identifying the risk of distal
mbolization by VH-IVUS will lead to selective use of
djunctive distal protection techniques and improved clini-
al outcome, to perform VH-IVUS of the culprit lesion in
TEMI, the authors had to perform thrombectomy first,
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Editorial Comment October 23, 2007:1647–8hich added time and in itself triggered distal embolization
n 18% of cases—hardly a desirable outcome (8). Fourth,
ven if we could accurately predict lesions most likely to
ause distal embolization, can distal embolization be pre-
ented and, if so, does that translate into better ventriculo-
raphic or clinical outcome? Several studies have shown that
djunctive use of distal protection devices with PCI in ACS
educes distal embolization; however, despite such success, a
ajority of the randomized controlled clinical trials have
ailed to demonstrate any beneficial impact of distal protec-
ion devices on infarct size, left ventricular function and
emodeling, or clinical outcome (15–21). These discourag-
ng outcomes data have once again raised the question of
hether distal protection devices are effective in eliminating
ll distal emboli or whether distal embolization leading to
low flow or no-reflow after PCI is more a marker or
orrelate of myocardial damage rather than an important
ontributor to myocardial damage. Not withstanding these
imitations, the 2 reports in this issue of the Journal provide
otentially interesting information that needs to be vali-
ated prospectively in larger cohorts of patients. The clinical
ignificance of post-PCI distal embolization, the effective-
ess of distal protection devices in preventing embolization,
nd the ultimate impact of reducing distal embolization on
obust markers of clinical outcome remain uncertain and
arrant further investigation.
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